GlassScriptPhysician profile
Thomas A Rockoff
NPI 1356313944
$16,842.11
in general payments reported to CMS, 2019-2025
49 companies · $3,378 in 2025
The $3,378 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,823 · 2020: $771 · 2021: $2,050 · 2022: $3,150 · 2023: $2,495 · 2024: $3,175 · 2025: $3,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,979 · Education: $69.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,978.86 |
| Education | $69.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,156.32 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $1,969.07 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Gilead Sciences, INC. | $1,441.70 | 2019-2025 | |
| Janssen Biotech, INC. | $1,118.99 | 2019-2025 | Stelara, Tremfya, Simponi Aria |
| Pfizer INC. | $1,046.48 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $801.23 | 2019-2025 | Trulance, Xifaxan, Relistor |
| Celgene Corporation | $770.32 | 2021-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $626.29 | 2019-2024 | Linzess |
| Intercept Pharmaceuticals, INC. | $415.63 | 2019-2025 | Ocaliva |
| Qol Medical, LLC | $393.79 | 2019-2025 | Sucraid |
| Lilly USA, LLC | $374.16 | 2024-2025 | Omvoh, Zepbound |
| Ardelyx, INC. | $355.69 | 2022-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $346.70 | 2024-2025 | Rezdiffra, Resmetirom |
| Phathom Pharmaceuticals, INC. | $305.33 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $263.92 | 2019-2024 | Dificid |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $220.87 | 2024-2025 | Iqirvo |
| Organon LLC | $185.02 | 2021-2025 | Renflexis, Hadlima |
| Allergan, INC. | $180.30 | 2019-2020 | |
| Celltrion USA INC. | $175.14 | 2024-2025 | Vegzelma, Zymfentra |
| Evoke Pharma, INC. | $158.40 | 2021-2023 | Gimoti |
| Daiichi Sankyo INC. | $145.27 | 2019-2022 | |
| Exact Sciences Corporation | $141.30 | 2023-2024 | Cologuard Collection Kit |
| Redhill Biopharma INC. | $120.58 | 2020-2023 | Talicia, Aemcolo, Movantik |
| Genzyme Corporation | $107.69 | 2024 | |
| Covidien LP | $96.00 | 2020 | |
| Medtronic, INC. | $95.47 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $91.27 | 2021 | |
| Novo Nordisk INC | $86.53 | 2024-2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $65.14 | 2022-2024 | Dupixent |
| Aimmune Therapeutics, INC. | $55.63 | 2024-2025 | Vowst |
| Amgen INC. | $55.50 | 2023 | Avsola, Amjevita |
| Shionogi INC | $53.65 | 2019-2020 | |
| Fresenius Kabi USA, LLC | $49.80 | 2023 | Idacio |
| Laborie Medical Technologies Corp. | $38.64 | 2025 | Alphaone |
| Fujifilm Healthcare Americas Corporation | $37.72 | 2022 | |
| Nestle Healthcare Nutrition INC. | $35.87 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.12 | 2019-2022 | |
| Braintree Laboratories, INC. | $32.64 | 2025 | Sutab, Suflave |
| Ultragenyx Pharmaceutical INC. | $23.50 | 2024 | Dojolvi |
| Tanabe Pharma America, INC. | $21.48 | 2019 | |
| Lucid Diagnostics INC. | $20.31 | 2023 | |
| Teleflex LLC | $19.12 | 2023 | Urolift |
| Intra-Sana Laboratories | $18.64 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ferring Pharmaceuticals INC. | $18.29 | 2019 | |
| Ambu INC. | $17.29 | 2021 | |
| Alfasigma USA, INC. | $15.74 | 2020 | |
| Shire North American Group INC | $15.46 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rockoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.